BRISBANE-BASED Cannatrek has today announced the upcoming release of its first prescription medicinal cannabis oil and flow products in Australia, as well as securing an export supply agreement to the UK.
The company said it had identified "more than 18 high-value strains of medicinal cannabis" after several years of research, with eight of those chosen for development to release to Australian patients via pharmacies, for the treatment of a range of conditions including pain, inflammation, anxiety and insomnia.
Cannatrek CEO, Tommy Huppert, said the company had so far sold over $2 million of product in Australia, with hundreds of doctors prescribing medicinal cannabis for use by thousands of patients "and prices are coming down".
The above article was sent to subscribers in Pharmacy Daily's issue from 12 Oct 20
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 Oct 20
